Items where Author is "107261"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Year | Item Type | Full Text
Jump to: 2018 | 2017 | 2016 | 2013 | 2012 | 2011
Number of items: 12.


Walker, J; Burke, K; Wanat, M; Fisher, R; Fielding, J; Mulick, A; Puntis, S; Sharpe, J; Esposti, MD; Harriss, E; +2 more... (2018) The prevalence of depression in general hospital inpatients: a systematic review and meta-analysis of interview-based studies. Psychological medicine. pp. 1-14. ISSN 0033-2917 DOI:
[img] [img]


Frost, C; Mulick, A; Scahill, RI; Owen, G; Aylward, E; Leavitt, BR; Durr, A; Roos, RAC; Borowsky, B; Stout, JC; +5 more... (2017) Design optimization for clinical trials in early-stage manifest Huntington's disease. Movement disorders. ISSN 0885-3185 DOI:
[img] [img]


Charoen, P; Nitsch, D; Engmann, J; Shah, T; White, J; Zabaneh, D; Jefferis, B; Wannamethee, G; Whincup, P; Mulick Cassidy, A; +31 more... (2016) Mendelian Randomisation study of the influence of eGFR on coronary heart disease. Scientific reports, 6. p. 28514. ISSN 2045-2322 DOI:


Omlin, A; Pezaro, C; Mukherji, D; Mulick Cassidy, A; Sandhu, S; Bianchini, D; Olmos, D; Ferraldeschi, R; Maier, G; Thompson, E; +3 more... (2013) Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms. European urology, 64 (2). pp. 300-6. ISSN 0302-2838 DOI: Full text not available from this repository.

Pezaro, C; Mukherji, D; Tunariu, N; Cassidy, AM; Omlin, A; Bianchini, D; Seed, G; Reid, AH; Olmos, D; de Bono, JS; +1 more... (2013) Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer. British journal of cancer, 109 (2). pp. 325-31. ISSN 0007-0920 DOI:


Attard, G; Reid, AH; Auchus, RJ; Hughes, BA; Cassidy, AM; Thompson, E; Oommen, NB; Folkerd, E; Dowsett, M; Arlt, W; +1 more... (2012) Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer. The Journal of clinical endocrinology and metabolism, 97 (2). pp. 507-16. ISSN 0021-972X DOI: Full text not available from this repository.

Perkins, G; Yap, TA; Pope, L; Cassidy, AM; Dukes, JP; Riisnaes, R; Massard, C; Cassier, PA; Miranda, S; Clark, J; +8 more... (2012) Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers. PLoS One, 7 (11). e47020. ISSN 1932-6203 DOI:


This list was generated on Thu Nov 8 08:24:39 2018 GMT.